Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

118.76
Delayed Data
As of 3:59pm ET
 +1.82 / +1.56%
Today’s Change
67.81
Today|||52-Week Range
124.72
+31.55%
Year-to-Date

Today’s Trading

Previous close116.94
Today’s open117.93
Day’s range116.36 - 118.99
Volume262,123
Average volume (3 months)559,325
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+37.91%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio126.3
Price/Sales12.92
Price/Book13.51

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.51+0.63%
NUVANuVasive Inc+0.68+1.07%
IARTIntegra LifeSciences...+0.92+1.08%
CMNCantel Medical Corp+0.25+0.35%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs